NEWS - September 30, 2013
NeuroTrax Signs Deal to Increase Research Services to Brainsway
NeuroTrax Corporation signed a deal with Brainsway Ltd. (BRIN.TA) to provide cognitive testing services for its multi-center research program. The current contract builds upon and expands successful service provided to Brainsway since 2008. Brainsway is an innovative developer of deep Transcranial Magnetic Stimulation (TMS) products for use in treatment of multiple brain disorders and recently achieved FDA approval in the US for treatment of depression. Brainsway maintains an active portfolio of clinical research in the US, Europe, and the Middle East to establish additional clinical indications for use of its deep TMS products.
NeuroTrax provides research services to pharmaceutical and medical device companies as well as academic investigators in need of validated and standardized cognitive measures for their clinical trials. Services include data collection, data analysis, investigator training, customization, and software services.
Brainsway Ltd. Homepage